{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:36:20Z","timestamp":1782207380575,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Hepatic hydrothorax (HH) is a predictor of poor survival in cirrhosis patients. However, whether HH increases the mortality risk of cirrhosis patients treated with transjugular intrahepatic portosystemic shunt (TIPS) is unknown. Our objective was to evaluate the influence of HH on the survival of cirrhosis patients after TIPS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Cirrhosis patients with portal hypertension complications were selected from a prospective database of consecutive patients treated with TIPS in Xijing Hospital from January 2015 to June 2021. Cirrhosis patients with HH were treated as the experimental group. A control group of cirrhosis patients without HH was created using propensity score matching. Survival after TIPS and the related risk factors were analysed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 1292 cirrhosis patients with portal hypertension complications treated with TIPS, among whom 255 patients had HH. Compared with patients without HH, patients with HH had worse liver function (MELD, 12 vs. 10, <jats:italic>p<\/jats:italic> &lt; 0.001), but no difference in survival after TIPS was observed. After propensity score matching, 243 patients with HH and 243 patients without HH were enrolled. There was no difference in cumulative survival between patients with and without HH. Cox regression analysis showed that HH was not associated with survival after TIPS, and main portal vein thrombosis (&gt; 50%) was a prognostic factor of long-term survival after TIPS in cirrhosis patients (hazard ratio, 1.386; 95% CI, 1.030\u20131.865, <jats:italic>p<\/jats:italic> = 0.031).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Hepatic hydrothorax does not increase the risk of death after TIPS in cirrhosis patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key Points<\/jats:title>\n                <jats:p>\u2022 <jats:italic>Hepatic hydrothorax is a decompensated event of cirrhosis and increases the risk of death.<\/jats:italic><\/jats:p>\n                <jats:p>\u2022 <jats:italic>Hepatic hydrothorax is associated with worse liver function.<\/jats:italic><\/jats:p>\n                <jats:p>\u2022 <jats:italic>Hepatic hydrothorax does not increase the mortality of cirrhosis treated with TIPS.<\/jats:italic><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00330-022-09357-3","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T07:02:48Z","timestamp":1672210968000},"page":"3407-3415","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients"],"prefix":"10.1007","volume":"33","author":[{"given":"Xiaoyuan","family":"Gou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangye","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3669-0467","authenticated-orcid":false,"given":"Jun","family":"Tie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"key":"9357_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5604\/01.3001.0010.7533","volume":"17","author":"Y Lv","year":"2018","unstructured":"Lv Y, Han G, Fan D (2018) Hepatic hydrothorax. Ann Hepatol 17:33\u201346","journal-title":"Ann Hepatol"},{"key":"9357_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3350\/cmh.2018.1005","volume":"24","author":"Korean Association for the Study of the L","year":"2018","unstructured":"Korean Association for the Study of the L (2018) KASL clinical practice guidelines for liver cirrhosis: ascites and related complications. Clin Mol Hepatol 24:230\u2013277","journal-title":"Clin Mol Hepatol"},{"key":"9357_CR3","first-page":"558","volume":"52","author":"K Malagari","year":"2005","unstructured":"Malagari K, Nikita A, Alexopoulou E et al (2005) Cirrhosis-related intrathoracic disease. Imaging features in 1038 patients. Hepatogastroenterology 52:558\u2013562","journal-title":"Hepatogastroenterology"},{"key":"9357_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jhep.2013.03.026","volume":"59","author":"MJ Krowka","year":"2013","unstructured":"Krowka MJ, Wiesner RH, Heimbach JK (2013) Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol 59:367\u2013374","journal-title":"J Hepatol"},{"key":"9357_CR5","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31434","volume":"72","author":"BA Banini","year":"2020","unstructured":"Banini BA, Alwatari Y, Stovall M et al (2020) Multidisciplinary management of hepatic hydrothorax in 2020: an evidence-based review and guidance. Hepatology 72:1851\u20131863","journal-title":"Hepatology"},{"key":"9357_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/MD.0000000000000025","volume":"93","author":"R Badillo","year":"2014","unstructured":"Badillo R, Rockey DC (2014) Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature. Medicine (Baltimore) 93:135\u2013142","journal-title":"Medicine (Baltimore)"},{"key":"9357_CR7","first-page":"566","volume":"26","author":"A Abbasi","year":"2016","unstructured":"Abbasi A, Bhutto AR, Alam MT et al (2016) Frequency of hepatic hydrothorax and its association with Child Pugh class in liver cirrhosis patients. J Coll Physicians Surg Pak 26:566\u2013569","journal-title":"J Coll Physicians Surg Pak"},{"key":"9357_CR8","first-page":"867","volume":"94","author":"L Mouelhi","year":"2016","unstructured":"Mouelhi L, Daboussi O, Cheffi N et al (2016) Hepatic hydrothorax: about a hospital serie of 63 cases. Tunis Med 94:867","journal-title":"Tunis Med"},{"key":"9357_CR9","doi-asserted-by":"crossref","unstructured":"Matei D, Craciun R, Crisan D et al (2021) Hepatic hydrothorax-an independent decompensating event associated with long-term mortality in patients with cirrhosis. J Clin Med:10","DOI":"10.3390\/jcm10163688"},{"key":"9357_CR10","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1007\/s10620-020-06677-6","volume":"66","author":"JG O'Leary","year":"2021","unstructured":"O'Leary JG, Rajender Reddy K, Tandon P et al (2021) Increased risk of ACLF and inpatient mortality in hospitalized patients with cirrhosis and hepatic hydrothorax. Dig Dis Sci 66:3612\u20133618","journal-title":"Dig Dis Sci"},{"key":"9357_CR11","doi-asserted-by":"crossref","unstructured":"Deleuran T, Watson H, Vilstrup H et al (2022) Risk factors for hepatic hydrothorax in cirrhosis patients with ascites - a clinical cohort study. Dig Dis Sci\u00a067:3395\u20133401","DOI":"10.1007\/s10620-021-07134-8"},{"key":"9357_CR12","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1007\/s10620-022-07522-8","volume":"67","author":"KT Osman","year":"2022","unstructured":"Osman KT, Abdelfattah AM, Mahmood SK et al (2022) Refractory hepatic hydrothorax is an independent predictor of mortality when compared to refractory ascites. Dig Dis Sci 67:4929\u20134938","journal-title":"Dig Dis Sci"},{"key":"9357_CR13","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.cgh.2021.07.018","volume":"20","author":"JR Boike","year":"2022","unstructured":"Boike JR, Thornburg BG, Asrani SK et al (2022) North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension. Clin Gastroenterol Hepatol 20:1636\u20131662.e36","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9357_CR14","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1007\/s10620-016-4260-9","volume":"61","author":"F Hou","year":"2016","unstructured":"Hou F, Qi X, Guo X (2016) Effectiveness and safety of pleurodesis for hepatic hydrothorax: a systematic review and meta-analysis. Dig Dis Sci 61:3321\u20133334","journal-title":"Dig Dis Sci"},{"key":"9357_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ajg.2009.634","volume":"105","author":"R Dhanasekaran","year":"2010","unstructured":"Dhanasekaran R, West JK, Gonzales PC et al (2010) Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am J Gastroenterol 105:635\u2013641","journal-title":"Am J Gastroenterol"},{"key":"9357_CR16","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.4254\/wjh.v7.i13.1797","volume":"7","author":"IC Ditah","year":"2015","unstructured":"Ditah IC, Al Bawardy BF, Saberi B et al (2015) Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: a systematic review and cumulative meta-analysis. World J Hepatol 7:1797\u20131806","journal-title":"World J Hepatol"},{"key":"9357_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/00042737-200105000-00011","volume":"13","author":"V Siegerstetter","year":"2001","unstructured":"Siegerstetter V, Deibert P, Ochs A et al (2001) Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 13:529\u2013534","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9357_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"European Association for the Study of the Liver. Electronic address eee and European Association for the Study of the L","year":"2018","unstructured":"European Association for the Study of the Liver. Electronic address eee and European Association for the Study of the L (2018) EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol 69:406\u2013460","journal-title":"J Hepatol"},{"key":"9357_CR19","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/liv.13615","volume":"38","author":"T Bucsics","year":"2018","unstructured":"Bucsics T, Hoffman S, Grunberger J et al (2018) ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis. Liver Int 38:1036\u20131044","journal-title":"Liver Int"},{"key":"9357_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","volume":"152","author":"C Bureau","year":"2017","unstructured":"Bureau C, Thabut D, Oberti F et al (2017) Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterology 152:157\u2013163","journal-title":"Gastroenterology"},{"issue":"193-205","key":"9357_CR21","volume":"160","author":"O Nicoara-Farcau","year":"2021","unstructured":"Nicoara-Farcau O, Han G, Rudler M et al (2021) Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data. Gastroenterology 160(193-205):e110","journal-title":"Gastroenterology"},{"key":"9357_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/gutjnl-2020-321790","volume":"70","author":"GP Aithal","year":"2021","unstructured":"Aithal GP, Palaniyappan N, China L et al (2021) Guidelines on the management of ascites in cirrhosis. Gut 70:9\u201329","journal-title":"Gut"},{"key":"9357_CR23","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.acra.2015.03.015","volume":"22","author":"D Chiao","year":"2015","unstructured":"Chiao D, Hanley M, Olazagasti JM (2015) CT volumetric analysis of pleural effusions: a comparison with thoracentesis volumes. Acad Radiol 22:1122\u20131127","journal-title":"Acad Radiol"},{"key":"9357_CR24","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0016-5085(98)70059-9","volume":"115","author":"PC Ter Borg","year":"1998","unstructured":"Ter Borg PC, Van Donselaar M, Van Buuren HR (1998) Clinical events after TIPS: correlation with hemodynamic findings. Gastroenterology 115:1607","journal-title":"Gastroenterology"},{"key":"9357_CR25","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1016\/S0002-9270(01)03902-8","volume":"96","author":"M Rossle","year":"2001","unstructured":"Rossle M, Siegerstetter V, Olschewski M et al (2001) How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol 96:3379\u20133383","journal-title":"Am J Gastroenterol"},{"key":"9357_CR26","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1007\/s10620-022-07523-7","volume":"67","author":"JC Asotibe","year":"2022","unstructured":"Asotibe JC, Banini BA (2022) Hepatic hydrothorax: an independent predictor of mortality in cirrhosis? Is the MELD-Na Score Worth Its Salt? Dig Dis Sci 67:4609\u20134611","journal-title":"Dig Dis Sci"},{"key":"9357_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.diii.2018.10.006","volume":"100","author":"S Young","year":"2019","unstructured":"Young S, Bermudez J, Zhang L et al (2019) Transjugular intrahepatic portosystemic shunt (TIPS) placement: a comparison of outcomes between patients with hepatic hydrothorax and patients with refractory ascites. Diagn Interv Imaging 100:303\u2013308","journal-title":"Diagn Interv Imaging"},{"key":"9357_CR28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","volume":"133","author":"F Salerno","year":"2007","unstructured":"Salerno F, Camma C, Enea M et al (2007) Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 133:825\u2013834","journal-title":"Gastroenterology"},{"key":"9357_CR29","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.crad.2015.02.002","volume":"70","author":"RC Gaba","year":"2015","unstructured":"Gaba RC, Parvinian A, Casadaban LC et al (2015) Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis. Clin Radiol 70:e51\u2013e57","journal-title":"Clin Radiol"},{"key":"9357_CR30","first-page":"382","volume":"14","author":"JD Perkins","year":"2008","unstructured":"Perkins JD (2008) Liver function determines success of transjugular intrahepatic portosystemic shunt in treating hepatic hydrothorax. Liver Transpl 14:382\u2013383","journal-title":"Liver Transpl"},{"key":"9357_CR31","first-page":"6","volume":"70","author":"JY Wilputte","year":"2007","unstructured":"Wilputte JY, Goffette P, Zech F et al (2007) The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients. Acta Gastroenterol Belg 70:6\u201310","journal-title":"Acta Gastroenterol Belg"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-09357-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-022-09357-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-09357-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T12:06:49Z","timestamp":1682078809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-022-09357-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["9357"],"URL":"https:\/\/doi.org\/10.1007\/s00330-022-09357-3","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,28]]},"assertion":[{"value":"5 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Tie Jun.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study has been approved by the Medical Ethics Committee of the First Affiliated Hospital of Air Force Medical University (approval number: KY20222200-C-1).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 case\u2013control study","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}